Shimizu K, Nakao A
Department of Internal Medicine, Tokyo Rosai (Occupational Diseases and Injuries) Hospital, Japan.
Endocrinol Jpn. 1992 Oct;39(5):517-23. doi: 10.1507/endocrj1954.39.517.
Whether or not 1-desamino-8-D-arginine-vasopressin (DDAVP) reduces blood pressure or affects the release of arginine vasopressin (AVP) and renin is controversial, although evidence suggests AVP and renin are important in maintaining blood pressure during hemorrhage. We therefore investigated the effect of DDAVP on endogenous release of AVP and renin and on blood pressure during hemorrhage in dogs. In the control group the hemorrhage was performed at a rate of 0.4 ml.kg-1.min-1 for 40 min from the femoral artery. The plasma AVP concentration and renin activity (PRA) increased progressively in response to the hemorrhage, from 7.5 +/- 0.5 to 40.3 +/- 7.3 pg.ml-1, and from 11.8 +/- 1.5 to 20.5 +/- 4.2 ng.ml-1.h-1, respectively, while blood pressure decreased slightly. In the DDAVP group, intravenous infusion of DDAVP (2.5 ng.kg-1.min-1 for 40 min) and hemorrhage were simultaneously performed. The plasma DDAVP concentration increased progressively to 218 +/- 21.0 pg.ml-1. There was no significant difference, however, between the control and DDAVP groups in the response of AVP, PRA and blood pressure. The results suggested that DDAVP may not affect the release of AVP and renin or blood pressure during hemorrhage.
1-去氨基-8-D-精氨酸血管加压素(DDAVP)是否能降低血压或影响精氨酸血管加压素(AVP)和肾素的释放存在争议,尽管有证据表明AVP和肾素在出血期间维持血压方面很重要。因此,我们研究了DDAVP对犬出血期间AVP和肾素内源性释放以及血压的影响。对照组从股动脉以0.4 ml·kg-1·min-1的速率出血40分钟。出血后,血浆AVP浓度和肾素活性(PRA)分别从7.5±0.5逐渐增加到40.3±7.3 pg·ml-1,以及从11.8±1.5逐渐增加到20.5±4.2 ng·ml-1·h-1,而血压略有下降。在DDAVP组中,同时进行静脉输注DDAVP(2.5 ng·kg-1·min-1,持续40分钟)和出血。血浆DDAVP浓度逐渐增加至218±21.0 pg·ml-1。然而,在AVP、PRA和血压的反应方面,对照组和DDAVP组之间没有显著差异。结果表明,DDAVP可能不会影响出血期间AVP和肾素的释放或血压。